Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
5.53
+0.14 (2.60%)
Sep 18, 2025, 11:23 AM EDT - Market open
Owens & Minor Revenue
Owens & Minor had revenue of $681.92M in the quarter ending June 30, 2025, with 3.26% growth. This brings the company's revenue in the last twelve months to $10.76B, up 64.35% year-over-year. In the year 2024, Owens & Minor had annual revenue of $10.70B with 3.55% growth.
Revenue (ttm)
$10.76B
Revenue Growth
+64.35%
P/S Ratio
0.04
Revenue / Employee
$463,726
Employees
23,200
Market Cap
427.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.70B | 366.92M | 3.55% |
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OMI News
- 2 days ago - Apria and Byram Join New Optum Preferred DME Network - Business Wire
- 12 days ago - AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 5 weeks ago - Owens & Minor Analysts Boost Their Forecasts After Q2 Results - Benzinga
- 5 weeks ago - Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade) - Seeking Alpha
- 5 weeks ago - Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - US Stocks Mixed; Owens & Minor Posts Downbeat Earnings - Benzinga
- 5 weeks ago - Owens & Minor Reports Second Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings - Benzinga